Which closed-end funds own Amylyx Pharmaceuticals Inc?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $13.2M. Security type: common equity. Country: United States. CUSIP 03237H101 · ISIN US03237H1014 · ticker AMLX.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.74% | $5.1M | 285,776 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.60% | $8.1M | 451,894 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “AMLX” → · Compare two funds’ portfolios →